This website is intended for healthcare professionals only.
Newsletter
MENU
MENU
News
Covid-19
Clinical
Albumin
Allergy
Gastroenterology
Radiology and Imaging
Cardiovascular
Oncology
Rheumatology
Connective tissue disorders
Paediatrics
Theatres and surgery
Emergency and critical care
Pathology and diagnostics
Wound care
Educational resources
Issues
2020
2019
2018
2017
2016
Sponsored
MENU
MENU
News
Covid-19
Clinical
Albumin
Allergy
Gastroenterology
Radiology and Imaging
Cardiovascular
Oncology
Rheumatology
Connective tissue disorders
Paediatrics
Theatres and surgery
Emergency and critical care
Pathology and diagnostics
Wound care
Educational resources
Issues
2020
2019
2018
2017
2016
Sponsored
Rheumatology
NHS on track to make £300m in savings after arthritis drug deals
Adalimumab biosimilar Imraldi launched in European Union
Treating giant cell arteritis
JAK inhibitors in the treatment of rheumatoid arthritis
Challenges in the management of psoriatic arthritis
Sobi launches new treatment for patients with rare inflammatory diseases
Anakinra receives positive opinion from CHMP for the treatment of Still’s disease
Adalimumab biosimilar approved in Europe for the treatment of multiple chronic inflammatory diseases
First patient randomised in study evaluating safety and efficacy of anakinra in Still’s disease
Efficacy and safety maintained in patients who switched from Humira to biosimilar
Positive CHMP opinion for adalimumab biosimilar
Sarilumab approved for the treatment of moderately to severely active rheumatoid arthritis in adults
Page 5 of 7
« First
«
...
3
4
5
6
7
»
Popular articles
Aspirin use associated with improved survival but only for bladder and breast cancer
18 January, 2021
Metformin use in diabetes protective against COVID-19-related mortality
18 January, 2021
Low levels of alcohol intake linked to greater risk of atrial fibrillation
18 January, 2021
Bimagrumab leads to significant fat loss in obese, type 2 diabetic patients
18 January, 2021
Higher convalescent plasma antibody titre levels associated with lower risk of death in COVID-19
18 January, 2021